Showing posts with label EClinical Solutions Market Research. Show all posts
Showing posts with label EClinical Solutions Market Research. Show all posts

Thursday, July 27, 2023

EClinical Solutions Market Global Synopsis, Future Scope, Top Key Players and Forecast to 2030

EClinical Solutions Market

The eClinical Solutions Market is projected to record a CAGR of 12% to influence earnings of USD 14.36 billion by 2030.

Clinical trials are increasingly growing complex, and there has been a massive increase in the amount of clinical data generated which calls for proper management. eClinical solutions are gaining momentum among pharmaceutical and biotechnology companies are progressively leveraging eClinical solutions to manage the huge volume of data.

 

The risks and costs associated with clinical trials continue to surge which puts enormous pressure on enterprises to optimize ROI in new drug development. eClinical solutions assist in automating and streamlining processes and thereby minimizes drug development costs.

Clinical research organizations (CRO) pharmaceutical companies are the primary end users for eClinical solutions and growth in the number of CROs is stimulating the growth of the global eClinical solutions market.

Other driving factors include expansion of R&D budget by pharma-biotech companies and rapid adoption of cloud computing technologies. However, the lack of skilled professionals to operate eClinical solutions, lack of research professionals, and the high cost of implementation are likely to dampen the growth of the global eClinical solutions market. Other restraining factors include concerns over data security, budgetary constraints faced by biotech and pharmaceutical companies and lack of awareness among the research community.

Major Key Players:

eClinical Solutions Inc, Medidata Solutions Inc, Datatrak International, ERT Clinical, Omnicomm Systems Inc, Parexel International Corporation, Maxisit Inc,

Merge Healthcare Inc, Bioclinica Inc, Oracle Corporation, and CRF Health are some of the EClinical Solutions Market Players in the market.

Segment Analysis

The global eClinical solution market has been segmented based product, delivery mode, and end-users.

Product-wise segmentation of the global eClinical solution market includes clinical data management systems (CDMS), randomization & trial supply management systems (RTMS), clinical analytics platform, electronic clinical outcome assessment (ECOA), clinical trial management systems (CTMS), clinical data integration platforms, safety solutions and electronic trial master files (ETMF), and electronic data capture (EDC).

By delivery mode, the global eClinical solution market has been segmented into web-hosted (on demand), licensed enterprise (on-premise) and cloud-based (SaaS).

By end users, the global eClinical solution market has been segmented into academic research organizations, consulting service companies, medical device manufacturers, hospitals, contract research organizations, and pharmaceutical companies.

Regional Analysis

The eClinical solutions market is spanned across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas is the largest market for eClinical solutions driven by a rise in a number of clinical trials in the region, increasing financial support from the government and presence of major players in the region.

 

Europe too is a significant market. High investment in R&D activities and the development of emerging economies which hold strong growth potential propel the growth of the eClinical solution market in Europe.

Asia Pacific market for eClinical solutions is expected to grow at the fastest rate over the forecast period. Increasing funding from the government to support clinical research and growth in a number of outsourcing of clinical trials in the developing economies of Asia Pacific boost the growth of the market. The Middle East & Africa market is expected to exhibit the least growth over the forecast period.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Thursday, February 23, 2023

EClinical Solutions Market 2022: Size, Share, Drivers, Restraints, Analysis and Forecast-2027

EClinical Solutions Market

The eClinical Solutions Market is projected to record a CAGR of 12% to influence earnings of USD 14,553 Million by 2027.

Clinical trials are increasingly growing complex, and there has been a massive increase in the amount of clinical data generated which calls for proper management. eClinical solutions are gaining momentum among pharmaceutical and biotechnology companies are progressively leveraging eClinical solutions to manage the huge volume of data.

 

The risks and costs associated with clinical trials continue to surge which puts enormous pressure on enterprises to optimize ROI in new drug development. eClinical solutions assist in automating and streamlining processes and thereby minimizes drug development costs.

Clinical research organizations (CRO) pharmaceutical companies are the primary end users for eClinical solutions and growth in the number of CROs is stimulating the growth of the global eClinical solutions market.

Other driving factors include expansion of R&D budget by pharma-biotech companies and rapid adoption of cloud computing technologies. However, the lack of skilled professionals to operate eClinical solutions, lack of research professionals, and the high cost of implementation are likely to dampen the growth of the global eClinical solutions market. Other restraining factors include concerns over data security, budgetary constraints faced by biotech and pharmaceutical companies and lack of awareness among the research community.

Major Key Players:

eClinical Solutions Inc, Medidata Solutions Inc, Datatrak International, ERT Clinical, Omnicomm Systems Inc, Parexel International Corporation, Maxisit Inc,

Merge Healthcare Inc, Bioclinica Inc, Oracle Corporation, and CRF Health are some of the EClinical Solutions Market Players in the market.

Segment Analysis

The global eClinical solution market has been segmented based product, delivery mode, and end-users.

Product-wise segmentation of the global eClinical solution market includes clinical data management systems (CDMS), randomization & trial supply management systems (RTMS), clinical analytics platform, electronic clinical outcome assessment (ECOA), clinical trial management systems (CTMS), clinical data integration platforms, safety solutions and electronic trial master files (ETMF), and electronic data capture (EDC).

By delivery mode, the global eClinical solution market has been segmented into web-hosted (on demand), licensed enterprise (on-premise) and cloud-based (SaaS).

By end users, the global eClinical solution market has been segmented into academic research organizations, consulting service companies, medical device manufacturers, hospitals, contract research organizations, and pharmaceutical companies.

Regional Analysis

The eClinical solutions market is spanned across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas is the largest market for eClinical solutions driven by a rise in a number of clinical trials in the region, increasing financial support from the government and presence of major players in the region.

 

Europe too is a significant market. High investment in R&D activities and the development of emerging economies which hold strong growth potential propel the growth of the eClinical solution market in Europe.

Asia Pacific market for eClinical solutions is expected to grow at the fastest rate over the forecast period. Increasing funding from the government to support clinical research and growth in a number of outsourcing of clinical trials in the developing economies of Asia Pacific boost the growth of the market. The Middle East & Africa market is expected to exhibit the least growth over the forecast period.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Wednesday, November 2, 2022

EClinical Solutions Market 2022: Size, Share, Analysis and Forecast-2027

 EClinical Solutions Market

The global eClinical Solutions Market is expected to have a market value of USD 13,209.14 million by 2027.

The eClinical Solutions Market suffered immensely because pet owners and farmers were encouraged to keep their animals at home. They were advised against taking their pets to the vet to get strong and effective vaccines like the Pfizer veterinary vaccines. Growth in the veterinary/eClinical Solutions Market is starting to pick up dramatically now that a vaccine for COVID-19 is being widely administered. Demand for animal vaccines is surging because livestock on farms around the world need these to remain healthy.

Major Key Players:

Some of the key players operating in the eClinical Solutions Market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Ceva Santé Animale (France), Merck & Co., Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Phibro Animal Health Corporation (US), Hipra (Spain), Biogénesis Bagó S.A.(Argentina), Neogen Corporation (US).

Segment Analysis

The global animal pharmaceuticals market is segmented into type, technology, and region. The type segment is further segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquacultutre vaccines. The technology segment is segmented into Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Recombinant vaccines, others.

Regional Analysis

The global palliative care market, based on region, has been divided into Americas, Europe, Asia-Pacific, and Middle East & Africa.

Americas dominated the global animal vaccine market due to various factors, such as the rising prevalence of animal diseases and the rise in pet ownership in the region. Furthermore, the high number of veterinary clinics in the region also boosts the growth of the market. There is an increasing prevalence of animal diseases such as foot & mouth disease, canine parvovirus, distemper, and reproductive & respiratory syndrome. Parvovirus infections are seen across the US and Canada. The American Veterinary Medical Association (AVMA) reported around 118,624 veterinary practitioners were operating in 2020. Similarly, according to the statistics published by the Canadian Veterinary Medical Association in 2020, about 12,921 veterinarians were present in Canada.

Europe accounted for a significant share in the market owing to a high population of companion animals in Europe, rising research and development investment, and increasing adoption of animal vaccines. According to the Industrial Association of Pet Care Producers, there are around 34 million pets in the UK, including dogs, cats, small mammals, and birds. In October 2021, Boehringer Ingelheim announced an additional 100 million EUR investment in its veterinary public health capabilities in Lyon-Jonage, France, to aid governments and public health organizations in managing future emerging and transboundary diseases. The additional investment will enable the adaptation of production lines for other emerging diseases, in particular swine and avian vaccines.

Asia-Pacific is expected to exhibit the highest CAGR during the forecast period of 2021-2027. This is due to lucrative opportunities for players operating in the animal vaccine market, a rise in the livestock population, and the increasing prevalence of animal diseases in the region. There is increasing awareness about animal health in the Asia-Pacific region. For instance, according to the report published by Pet Fair Asia and goumin.com, the total number of pet dogs and cats in China reached 99.15 million, with pet owners spending 29 billion US dollars in 2019. The increasing prevalence of animal diseases such as foot and mouth disease and avian influenza boosts the market growth in the region.

Middle East & Africa is expected to witness restricted growth compared to other regions due to limited access and healthcare affordability. The market growth in the region is driven by factors like the increasing incidence of zoonotic diseases and increasing pet adoption in the region. The common zoonotic disease diagnosed in this region is Rift Valley fever. Hence, emphasis is being put on promoting animal health in the region and improving healthcare services for companion animals.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Artificial Insemination Market Players, Share, Size, Trend, SWOT Analysis and Forecast to 2030

Artificial Insemination Market The artificial Insemination market   is expected to reach USD 8.9 billion by 2030 at CAGR of 8.6% during t...